|Hypochlorous acid is normally produced by myeloperoxidase|
|Classification and external resources|
Myeloperoxidase deficiency is an autosomal recessive genetic disorder featuring deficiency, either in quantity or of function, of myeloperoxidase, an enzyme found in certain phagocytic immune cells, especially polymorphonuclear leukocytes.
The lack of severe symptoms suggest that role of myeloperoxidase in the immune response must be redundant to other mechanisms of intracellular killing of phagocytosed bacteria.
Patients with MPO deficiency have a respiratory burst with a normal nitro blue tetrazolium (NBT) test because they still have NADPH oxidase activity, but do not form bleach due to their lack of myeloperoxidase activity. This is in contrast to chronic granulomatous disease, in which the NBT test is 'negative' due to the lack of NADPH oxidase activity (positive test result means neutrophils turn blue, negative means nitroblue tetrazolium remains yellow).
Patients with MPO deficiency are at increased risk for systemic candidiasis.
- Mauch L, Lun A, O'Gorman MR, Harris JS, Schulze I, Zychlinsky A, Fuchs T, Oelschlägel U, Brenner S, Kutter D, Rösen-Wolff A, Roesler J (2007). "Chronic granulomatous disease (CGD) and complete myeloperoxidase deficiency both yield strongly reduced dihydrorhodamine 123 test signals but can be easily discerned in routine testing for CGD". Clinical Chemistry. 53 (5): 890–6. doi:10.1373/clinchem.2006.083444. PMID 17384005.
- Levinson, Warren. "Medical Microbiology & Immunology, 8th ed." Lange:2004.[page needed]
- Lehrer RI, Cline MJ (1969). "Leukocyte myeloperoxidase deficiency and disseminated candidiasis: the role of myeloperoxidase in resistance to Candida infection". The Journal of Clinical Investigation. 48 (8): 1478–88. doi:10.1172/JCI106114. PMC . PMID 5796360.
|This immunology article is a stub. You can help Wikipedia by expanding it.|
|This genetic disorder article is a stub. You can help Wikipedia by expanding it.|